Your browser is no longer supported. Please, upgrade your browser.
Settings
BNGO [NASD]
Bionano Genomics, Inc.
Index- P/E- EPS (ttm)-0.26 Insider Own0.30% Shs Outstand278.90M Perf Week-3.36%
Market Cap1.37B Forward P/E- EPS next Y-0.25 Insider Trans0.00% Shs Float278.20M Perf Month0.58%
Income-51.30M PEG- EPS next Q-0.06 Inst Own26.90% Short Float16.32% Perf Quarter-28.39%
Sales13.20M P/S104.02 EPS this Y80.20% Inst Trans79.75% Short Ratio4.43 Perf Half Y-42.87%
Book/sh1.24 P/B4.17 EPS next Y-13.60% ROA-24.30% Target Price- Perf Year737.79%
Cash/sh1.25 P/C4.13 EPS next 5Y- ROE-27.00% 52W Range0.47 - 15.69 Perf YTD67.86%
Dividend- P/FCF- EPS past 5Y- ROI-75.10% 52W High-66.93% Beta-
Dividend %- Quick Ratio31.40 Sales past 5Y- Gross Margin33.30% 52W Low994.75% ATR0.29
Employees147 Current Ratio31.90 Sales Q/Q225.00% Oper. Margin- RSI (14)40.31 Volatility5.01% 5.08%
OptionableYes Debt/Eq0.00 EPS Q/Q24.20% Profit Margin- Rel Volume0.72 Prev Close5.17
ShortableYes LT Debt/Eq0.00 EarningsAug 04 AMC Payout- Avg Volume10.25M Price5.19
Recom1.20 SMA20-7.79% SMA50-10.51% SMA200-22.19% Volume3,574,388 Change0.35%
Jun-16-21Initiated BTIG Research Buy $10
Sep-24-20Initiated Ladenburg Thalmann Buy $1.25
Apr-08-20Initiated Oppenheimer Outperform $1.50
Sep-16-21 08:00AM  
05:51AM  
Sep-07-21 08:00AM  
Aug-26-21 08:00AM  
Aug-19-21 09:49AM  
Aug-09-21 10:23AM  
Aug-05-21 04:01AM  
Aug-04-21 06:15PM  
04:05PM  
Jul-29-21 12:51PM  
Jul-28-21 04:30PM  
Jul-27-21 08:00AM  
Jul-26-21 05:50PM  
Jul-23-21 04:56PM  
Jul-19-21 08:00AM  
Jul-16-21 08:07AM  
07:01AM  
Jul-14-21 08:00AM  
Jul-13-21 08:00AM  
Jul-09-21 11:44AM  
Jul-07-21 11:00AM  
08:52AM  
06:06AM  
Jul-06-21 08:00AM  
Jul-02-21 05:50PM  
08:00AM  
Jul-01-21 04:05PM  
Jun-28-21 08:00AM  
Jun-25-21 11:13AM  
Jun-24-21 05:50PM  
05:19AM  
Jun-23-21 08:27AM  
Jun-22-21 09:46AM  
Jun-16-21 01:25PM  
Jun-14-21 08:00AM  
06:15AM  
04:34AM  
Jun-08-21 07:18AM  
Jun-07-21 05:07PM  
08:00AM  
Jun-04-21 05:52AM  
May-29-21 07:07AM  
May-28-21 11:57AM  
May-19-21 04:05PM  
May-18-21 01:28PM  
May-17-21 06:06AM  
May-16-21 03:18AM  
May-14-21 03:23PM  
11:28AM  
06:08AM  
06:02AM  
12:00AM  
May-13-21 06:15PM  
04:24PM  
04:01PM  
02:30PM  
May-12-21 08:37AM  
May-10-21 10:58AM  
May-07-21 02:02PM  
May-06-21 04:01PM  
May-04-21 08:00AM  
May-03-21 08:00AM  
Apr-30-21 10:12AM  
Apr-28-21 05:50PM  
Apr-23-21 12:12PM  
09:36AM  
06:30AM  
Apr-22-21 08:00AM  
Apr-21-21 08:00AM  
Apr-20-21 07:21AM  
Apr-18-21 06:00AM  
Apr-16-21 11:24AM  
Apr-15-21 06:01AM  
Apr-14-21 08:00AM  
Apr-12-21 08:00AM  
Apr-09-21 04:21PM  
Apr-07-21 04:30PM  
08:00AM  
Apr-06-21 11:30AM  
08:00AM  
Apr-02-21 03:02PM  
11:16AM  
Mar-27-21 01:36PM  
Mar-24-21 06:00AM  
01:30AM  
Mar-23-21 05:05PM  
04:01PM  
02:30PM  
05:30AM  
Mar-22-21 10:04AM  
Mar-18-21 02:42PM  
Mar-15-21 08:30AM  
Mar-12-21 05:50PM  
Mar-10-21 05:01PM  
Mar-09-21 04:30PM  
Mar-05-21 11:53AM  
08:53AM  
Mar-03-21 09:07AM  
Mar-02-21 08:22AM  
Mar-01-21 05:45PM  
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes. Its Saphyr system includes an instrument, chip consumables, reagents, a suite of data analysis tools, and genome analysis services for researchers to evaluate optical genome mapping data. The company's Bionano prep kits and labeling kits provide the reagents and protocols needed to extract and label ultra-high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stewart Christopher P.Chief Financial OfficerMay 26Option Exercise0.5625,00014,00033,000May 27 04:36 PM